XML 92 R80.htm IDEA: XBRL DOCUMENT v3.4.0.3
Condensed Consolidating Statements of Cash Flows (Detail) - USD ($)
$ in Thousands
 3 Months Ended
Mar. 31, 2016
Mar. 31, 2015
Cash flows from operating activities:    
Net income (loss) $ 138,159 $ (76,148)
Changes in operating assets and liabilities and non-cash items included in net income 290,843 486,237
Net cash provided by operating activities 429,002 410,089
Cash flows from investing activities:    
Additions of property and equipment (173,187) (121,421)
Acquisitions (405,154) (40,650)
Proceeds from asset and business sales 4,657 2,565
(Purchases) proceeds from investment sales and other items 19,373 (92,781)
Net cash used in investing activities (554,311) (252,287)
Cash flows from financing activities:    
Long-term debt and related financing costs, net (24,571) (28,439)
Other items (308,526) (82,429)
Net cash used in financing activities (333,097) (110,868)
Effect of exchange rate changes on cash 717 (904)
Net (decrease) increase in cash and cash equivalents (457,689) 46,030
Cash and cash equivalents at beginning of the year 1,499,116 965,241
Cash and cash equivalents at end of the period 1,041,427 1,011,271
Consolidation, Eliminations    
Cash flows from operating activities:    
Net income (loss) (132,743) 88,088
Changes in operating assets and liabilities and non-cash items included in net income 132,743 (88,088)
DaVita HealthCare Partners Inc. | Reportable Legal Entities    
Cash flows from operating activities:    
Net income (loss) 97,434 (110,617)
Changes in operating assets and liabilities and non-cash items included in net income (18,699) 154,352
Net cash provided by operating activities 78,735 43,735
Cash flows from investing activities:    
Additions of property and equipment (16,865) (6,230)
(Purchases) proceeds from investment sales and other items 23,387 (84,640)
Net cash used in investing activities 6,522 (90,870)
Cash flows from financing activities:    
Long-term debt and related financing costs, net (21,247) (21,250)
Intercompany borrowing (payments) (315,986) 180,207
Other items (267,551) (56,828)
Net cash used in financing activities (604,784) 102,129
Net (decrease) increase in cash and cash equivalents (519,527) 54,994
Cash and cash equivalents at beginning of the year 1,186,636 698,876
Cash and cash equivalents at end of the period 667,109 753,870
Guarantor Subsidiaries | Reportable Legal Entities    
Cash flows from operating activities:    
Net income (loss) 70,419 (133,144)
Changes in operating assets and liabilities and non-cash items included in net income 217,405 410,880
Net cash provided by operating activities 287,824 277,736
Cash flows from investing activities:    
Additions of property and equipment (86,055) (48,802)
Acquisitions (400,093) (40,018)
Proceeds from asset and business sales 4,657 2,565
(Purchases) proceeds from investment sales and other items (7,438) (537)
Net cash used in investing activities (488,929) (86,792)
Cash flows from financing activities:    
Long-term debt and related financing costs, net (1,977) (3,620)
Intercompany borrowing (payments) 167,702 (202,804)
Other items (756)  
Net cash used in financing activities 164,969 (206,424)
Net (decrease) increase in cash and cash equivalents (36,136) (15,480)
Cash and cash equivalents at beginning of the year 109,357 77,921
Cash and cash equivalents at end of the period 73,221 62,441
Non-Guarantor Subsidiaries | Reportable Legal Entities    
Cash flows from operating activities:    
Net income (loss) 103,049 79,525
Changes in operating assets and liabilities and non-cash items included in net income (40,606) 9,093
Net cash provided by operating activities 62,443 88,618
Cash flows from investing activities:    
Additions of property and equipment (70,267) (66,389)
Acquisitions (5,061) (632)
(Purchases) proceeds from investment sales and other items 3,424 (7,604)
Net cash used in investing activities (71,904) (74,625)
Cash flows from financing activities:    
Long-term debt and related financing costs, net (1,347) (3,569)
Intercompany borrowing (payments) 148,284 22,597
Other items (40,219) (25,601)
Net cash used in financing activities 106,718 (6,573)
Effect of exchange rate changes on cash 717 (904)
Net (decrease) increase in cash and cash equivalents 97,974 6,516
Cash and cash equivalents at beginning of the year 203,123 188,444
Cash and cash equivalents at end of the period $ 301,097 $ 194,960